Literature DB >> 20055945

Non-invasive papillary urothelial neoplasms: the 2004 WHO/ISUP classification system.

Hiroshi Miyamoto1, Jeremy S Miller, Daniel A Fajardo, Thomas K Lee, George J Netto, Jonathan I Epstein.   

Abstract

The classification and grading of papillary urothelial neoplasms has been a long-standing subject of controversy. Previously, numerous diverse grading schemes for bladder tumor, including the 1973 World Health Organization (WHO) classification, existed whereby one of the major limitations was poor inter-observer reproducibility among pathologists. The WHO/International Society of Urological Pathology (ISUP) consensus classification system of urothelial neoplasms of the urinary bladder was developed in 1998 and was revised most recently in 2003 (published in 2004). Importantly, the current classification system provides detailed histological criteria for papillary urothelial lesions and allows for designation of a lesion (papillary urothelial neoplasm of low malignant potential) with a negligible risk of progression. Thus, the latest system is designed to be a universally acceptable one for bladder tumors that not only could be effectively used by pathologists, urologists, and oncologists, but also stratifies the tumors into prognostically significant categories. This article outlines the 2004 WHO/ISUP classification system regarding the specific histological criteria for non-invasive papillary urothelial neoplasms and the clinical significance of each category.

Entities:  

Mesh:

Year:  2010        PMID: 20055945     DOI: 10.1111/j.1440-1827.2009.02477.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  55 in total

1.  Analysis of the Distribution and Temporal Trends of Grade and Stage in Urothelial Bladder Cancer in Northern New England from 1994 to 2004.

Authors:  Alan R Schned; Petra Lenz; Lee E Moore; Alison Johnson; Michael Jones; Masatoshi Kida; Debra T Silverman; Molly Schwenn; Karl T Kelsey; Angeline S Andrew; Dalsu Baris; Margaret R Karagas
Journal:  ISRN Pathol       Date:  2012

2.  Impact of 2004 ISUP/WHO classification on bladder cancer grading.

Authors:  Soum D Lokeshwar; Roberto Ruiz-Cordero; Marie C Hupe; Merce Jorda; Mark S Soloway
Journal:  World J Urol       Date:  2015-04-02       Impact factor: 4.226

3.  Relation of stem cell markers ALDH1 and CD44 with clinicopathological factors in urothelial carcinomas of urinary bladder.

Authors:  Serkan Senol; Asif Yildırım; Ibrahim Akalin; Fatih Uruç; Bengü Çobanoğlu; Sarenur Yilmaz; Bahar Ceyran; Duygu Kösemetin; Dilek Ece; Abdullah Aydın
Journal:  Int J Clin Exp Med       Date:  2015-03-15

4.  CARLo-7-A plausible biomarker for bladder cancer.

Authors:  Hina Amir; Mohammad Azam Khan; Saima Feroz; Nazia Bibi; Muhammad Nawaz; Arshad Mehmood; Arzu Yousuf; Mohammad Athar Khawaja; Muhammad Tahir Khadim; Aamira Tariq
Journal:  Int J Exp Pathol       Date:  2019-03-18       Impact factor: 1.925

5.  Genomic landscape of inverted urothelial papilloma and urothelial papilloma of the bladder.

Authors:  Sumit Isharwal; Wenhuo Hu; Judy Sarungbam; Ying-Bei Chen; Anuradha Gopalan; Samson W Fine; Satish K Tickoo; Sahussapont J Sirintrapun; Sana Jadallah; Florence L Loo; Eugene J Pietzak; Eugene K Cha; Bernard H Bochner; Michael F Berger; Gopa Iyer; David B Solit; Victor E Reuter; Hikmat Al-Ahmadie
Journal:  J Pathol       Date:  2019-04-22       Impact factor: 7.996

6.  Association of epithelial-mesenchymal transition and nuclear cofilin with advanced urothelial cancer.

Authors:  Patrick J Hensley; Daniel Zetter; Craig M Horbinski; Stephen E Strup; Natasha Kyprianou
Journal:  Hum Pathol       Date:  2016-07-08       Impact factor: 3.466

7.  Urothelial carcinoma of the urinary bladder in pediatric patients: a long-term follow-up.

Authors:  Haluk Ander; M İrfan Dönmez; Yasin Yitgin; Tzevat Tefik; Orhan Ziylan; Tayfun Oktar; Mehmet Özsoy
Journal:  Int Urol Nephrol       Date:  2015-03-19       Impact factor: 2.370

8.  Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder.

Authors:  Massimiliano Spaliviero; Guido Dalbagni; Bernard H Bochner; Bing Ying Poon; Hongying Huang; Hikmat A Al-Ahmadie; Timothy F Donahue; Jennifer M Taylor; Joshua J Meeks; Daniel D Sjoberg; S Machele Donat; Victor E Reuter; Harry W Herr
Journal:  J Urol       Date:  2014-03-03       Impact factor: 7.450

9.  Foxl1 inhibits tumor invasion and predicts outcome in human renal cancer.

Authors:  Feng-Qiang Yang; Feng-Ping Yang; Wei Li; Min Liu; Guang-Chun Wang; Jian-Ping Che; Jian-Hua Huang; Jun-Hua Zheng
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

10.  Up-regulation of miR-630 in clear cell renal cell carcinoma is associated with lower overall survival.

Authors:  Jian-Jun Zhao; Peng-Jie Chen; Rui-Qin Duan; Ke-Ji Li; Yu-Zhong Wang; Yong Li
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.